Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Metabolic associated fatty liver disease (MAFLD)"'
Autor:
Louise Wutsdorff, Julienne Mougnekabol, Peter Tang, Anja Reutzel-Selke, Igor M. Sauer, Nils Haep
Publikováno v:
Livers, Vol 4, Iss 3, Pp 406-419 (2024)
Cell-death-inducing DNA fragmentation factor-alpha (DFFA)-like effector b (CIDEB) was first identified as an apoptosis-inducing protein. Further research revealed a pivotal role in lipid metabolism, regulating very-low-density lipoprotein (VLDL), lip
Externí odkaz:
https://doaj.org/article/f12feb41a2b449f9b5171a9036c71ded
Autor:
Negar Abdi, Hamid Ghaznavi
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 55, Iss 1, Pp 1-6 (2024)
Abstract Background Liver injuries such as metabolic-associated fatty liver disease, liver fibrosis, and steatosis are common in COVID-19 patients. Unenhanced CT can be used to diagnose the morphological traits of steatosis and cirrhosis. This study
Externí odkaz:
https://doaj.org/article/39bf081af7fa41cc9fc0c8d4063b902a
Publikováno v:
Journal of Functional Foods, Vol 122, Iss , Pp 106554- (2024)
Ferulic acid (FA) is a natural phenolic acid with a strong protective effect against disorder of hepatic lipid metabolism. To elucidate the effect of FA on metabolic associated fatty liver disease (MAFLD), the physiological parameters of mice fed hig
Externí odkaz:
https://doaj.org/article/77dc6541b1ff4ceeae1d99c884928dd0
Autor:
Jin Imai, Shinji Takashimizu, Nana Suzuki, Kana Ohshinden, Kana Sawamoto, Yusuke Mishima, Kota Tsuruya, Yoshitaka Arase, Mitsuhiko Yamano, Noriaki Kishimoto, Chizumi Yamada, Nagamu Inoue, Kengo Moriyama, Akiyasu Baba, Hidekazu Suzuki, Tatehiro Kagawa, Yasuhiro Nishizaki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract A novel concept of Metabolic Associated Fatty Liver Disease (MAFLD) was proposed, incorporating metabolic abnormalities such as obesity and diabetes, which are risk factors that affect the prognosis. Non-Alcoholic Fatty Liver Disease (NAFLD)
Externí odkaz:
https://doaj.org/article/754dd757f5864b4b8113368be53e7250
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundAtherogenic Index of plasma (AIP) is closely related to metabolic abnormalities. But as of now, there is no definitive conclusion on the dose-response relationship pattern between AIP and metabolic associated fatty liver disease (MAFLD).Obj
Externí odkaz:
https://doaj.org/article/d1e1a900b97b45248cc9bd97cfb42ef4
Autor:
Khamis Al Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, Angelo Maria Patti, Khalid Al Waili, Khalid Al Rasadi, Marcello Ciaccio, Manfredi Rizzo
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
The definition of “Metabolic Associated Fatty Liver Disease – MAFLD” has replaced the previous definition of Nonalcoholic Fatty Liver Disease (NAFLD), because cardiometabolic criteria have been added for the prevention of cardiological risk in
Externí odkaz:
https://doaj.org/article/2d6aabb8e4784b0884bcb2b07aaf7f0b
Autor:
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundMetabolic associated fatty liver disease (MAFLD) is a novel terminology introduced in 2020 to provide a more accurate description of fatty liver disease associated with metabolic dysfunction. It replaces the outdated term nonalcoholic fatty
Externí odkaz:
https://doaj.org/article/2c5a3dfa737a46d5823df4977b01d78a
Autor:
Sun L, Zhao H, Ding XY, Yang K, Wang GS, Chen JM, Han XY, Wan G, Zhang L, Zhou XG, Chen XM, Wang P, Xie W
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 10, Pp 833-846 (2023)
Lei Sun,1 Hong Zhao,2 Xiao-Yan Ding,3 Kun Yang,1 Gui-Shuang Wang,4 Jia-Min Chen,1 Xiao-Yi Han,1 Gang Wan,5 Liang Zhang,1 Xin-Gang Zhou,1 Xiang-Mei Chen,1 Peng Wang,1 Wen Xie2 1Department of Pathology, Beijing Ditan Hospital, Capital Medical Universit
Externí odkaz:
https://doaj.org/article/e97f4948539641e390b54e185430ea8e
Autor:
Pingping Yu, Huachao Yang, Xiaoya Qi, Ruixue Bai, Shouqin Zhang, Jianping Gong, Ying Mei, Peng Hu
Publikováno v:
Lipids in Health and Disease, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background Since the discovery of metabolic-associated fatty liver disease (MAFLD) in 2020, no report on the connection between the visceral fat area (VFA) and MAFLD has been published in China, and the ideal cutoffs of VFA for predicting MA
Externí odkaz:
https://doaj.org/article/b6b926825e4e424aaddc9436d3f29f5b
Publikováno v:
Antioxidants, Vol 13, Iss 1, p 87 (2024)
Cardiometabolic disease (CMD), which encompasses metabolic-associated fatty liver disease (MAFLD), chronic kidney disease (CKD) and cardiovascular disease (CVD), has been increasing considerably in the past 50 years. CMD is a complex disease that can
Externí odkaz:
https://doaj.org/article/b5cf75432f7943c7a1bb947a2b4b6358